Institut Català de la Salut
[Vives J] Banc de Sang i Teixits, Edifici Dr. Frederic Duran i Jordà, Barcelona, Spain. Grup de Recerca en Enginyeria Tissular Musculoesquelètica, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Sòria MG] Banc de Sang i Teixits, Barcelona, Spain. [McGrath E] International Council for Commonality in Blood Banking Automation (ICCBBA), San Bernardino, USA. [Magri M] ASST Papa Giovanni XXIII, Bergamo, Italy
Vall d'Hebron Barcelona Hospital Campus
2022-09-14T08:08:29Z
2022-09-14T08:08:29Z
2022-07-05
Integrated management system; Quality compliance; Quality standards
Sistema de gestión integrado; Cumplimiento de la calidad; Estándares de calidad
Sistema de gestió integrat; Compliment de la qualitat; Estàndards de qualitat
Cell therapies are required to meet with compulsory regulations that co-exist with other optional standards and guidelines that together compose a complex quality management system. Indeed, reliable insights on the mechanisms of action and safety of novel cell-based therapies require adherence to solid quality management structures in all steps of the value chain, from early research and tissue procurement to clinical trials and biovigilance, thus guaranteeing reproducibility and solid foundations for better science and improved clinical practice. Herein we present the concept of the quality ecosystem as a tool to understand and assist all stakeholders involved in developing and structuring the integration of standards as novel developments are taking place. We conclude that the various quality management initiatives can all be thought about under the umbrella of an ecosystem.
Work in JV’s laboratory is supported by the Spanish Advanced Therapy Network (TERAV, expedient No. RD21/0017/0022), awarded by the Generalitat de Catalunya as Consolidated Research Group (ref. 2017SGR719) and funded by Ministerio de Ciencia Innovación y Universidades de España (Instituto de Salud Carlos III, expedient No. PI19/01788).
Article
Published version
English
Teràpia cel·lular; Assistència sanitària - Control de qualitat; ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Biological Therapy::Cell- and Tissue-Based Therapy; HEALTH CARE::Environment and Public Health::Environment::Ecosystem; PUBLIC HEALTH::Health Policy, Planning and Management::Health Administration::Health Management::Quality Management; TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::terapia biológica::tratamientos basados en células y tejidos; ATENCIÓN DE SALUD::ambiente y salud pública::ambiente::ecosistema; SALUD PÚBLICA::Políticas, Planificación y Administración en salud::administración en salud::gestión en salud::gestión de la calidad
MDPI
Cells;11(13)
https://doi.org/10.3390/cells11132112
info:eu-repo/grantAgreement/ES/PE2017-2020/RD21%2F0017%2F0022
info:eu-repo/grantAgreement/ES/PE2017-2020/PI19%2F01788
Attribution 4.0 International
http://creativecommons.org/licenses/by/4.0/
Articles científics - VHIR [1655]